In the present study, we provided first-time evidence that loss of miR-202-3p in breast cancer cells induces MMP-1 expression which grants tumor cells a higher brain invasive phenotype allowing them to induce alteration in the brain inter-endothelial junctions and to transmigrate though the brain endothelial barrier. Here, MMP1 is linked to breast carcinoma.